+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 45Years - 80Years
MALE
ID07454603

Evaluating PROSTest Diagnostic Accuracy for Prostate Cancer Detection in Men with Elevated PSA or Abnormal Exam

Led by Wren Laboratories LLC · Updated on 2026-08-21

1500

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective observational study to evaluate the diagnostic performance of PROSTest in men referred for prostate biopsy due to elevated PSA levels andor abnormal digital rectal examination. This study focuses on men aged 45 to 80 years and aims to compare PROSTest results with biopsy histopathology, the current standard for prostate cancer diagnosis. Participants will provide a peripheral blood sample before undergoing prostate biopsy. PROSTest analysis will be performed on these blood samples without knowledge of the biopsy results to ensure unbiased evaluation. The study will calculate diagnostic accuracy measures such as sensitivity, specificity, negative predictive value, and the area under the receiver operating characteristic curve. Additionally, the study will explore how PROSTest scores relate to MRI findings and pathologic grade groups. During the study, men will undergo blood collection and prostate biopsy as part of their clinical care. Researchers will analyze PROSTest diagnostic accuracy and secondary metrics after study completion, expected within 18 months. The study plans to enroll about 1,500 participants and monitor outcomes to assess PROSTests potential to reduce unnecessary biopsies and improve diagnostic decisions.

CONDITIONS

Brief Title

A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth

Research Team

M

Mark Kidd, PhD

T

Tracy Auster, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here